On March 4, 2021, Kizoo Technology Capital ("KIZOO") of Germany announced that it had provided seed funding for Elastrin Therapeutics ("Elastrin").
Elastrin is a biotechnology startup based in South Carolina and leveraging a platform technology to develop therapeutics that render calcified tissue and organs supple again.
Robert Hull of Gowling WLG advised one of the co-founders of Elastrin with respect to the negotiation of this funding.
"Read the original article on GowlingWLG.com".
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
